347 related articles for article (PubMed ID: 26156753)
1. Kallistatin inhibits TGF-β-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression.
Guo Y; Li P; Bledsoe G; Yang ZR; Chao L; Chao J
Exp Cell Res; 2015 Sep; 337(1):103-10. PubMed ID: 26156753
[TBL] [Abstract][Full Text] [Related]
2. Kallistatin attenuates endothelial senescence by modulating Let-7g-mediated miR-34a-SIRT1-eNOS pathway.
Guo Y; Chao L; Chao J
J Cell Mol Med; 2018 Sep; 22(9):4387-4398. PubMed ID: 29992759
[TBL] [Abstract][Full Text] [Related]
3. Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway.
Guo Y; Li P; Gao L; Zhang J; Yang Z; Bledsoe G; Chang E; Chao L; Chao J
Aging Cell; 2017 Aug; 16(4):837-846. PubMed ID: 28544111
[TBL] [Abstract][Full Text] [Related]
4. Role of Kallistatin Treatment in Aging and Cancer by Modulating miR-34a and miR-21 Expression.
Chao J; Guo Y; Li P; Chao L
Oxid Med Cell Longev; 2017; 2017():5025610. PubMed ID: 28744338
[TBL] [Abstract][Full Text] [Related]
5. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
Li P; Guo Y; Bledsoe G; Yang Z; Chao L; Chao J
Exp Cell Res; 2016 Jan; 340(2):305-14. PubMed ID: 26790955
[TBL] [Abstract][Full Text] [Related]
6. The mechanism of TGF-β/miR-155/c-Ski regulates endothelial-mesenchymal transition in human coronary artery endothelial cells.
Wang J; He W; Xu X; Guo L; Zhang Y; Han S; Shen D
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28607031
[TBL] [Abstract][Full Text] [Related]
7. Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation.
Chao J; Guo Y; Chao L
Oxid Med Cell Longev; 2018; 2018():4138560. PubMed ID: 30622668
[TBL] [Abstract][Full Text] [Related]
8. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress.
Shen B; Hagiwara M; Yao YY; Chao L; Chao J
Hypertension; 2008 May; 51(5):1358-65. PubMed ID: 18391098
[TBL] [Abstract][Full Text] [Related]
9. Oxidative Stress-Induced miR-200c Disrupts the Regulatory Loop Among SIRT1, FOXO1, and eNOS.
Carlomosti F; D'Agostino M; Beji S; Torcinaro A; Rizzi R; Zaccagnini G; Maimone B; Di Stefano V; De Santa F; Cordisco S; Antonini A; Ciarapica R; Dellambra E; Martelli F; Avitabile D; Capogrossi MC; Magenta A
Antioxid Redox Signal; 2017 Aug; 27(6):328-344. PubMed ID: 27960536
[TBL] [Abstract][Full Text] [Related]
10. Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signaling.
Shen B; Gao L; Hsu YT; Bledsoe G; Hagiwara M; Chao L; Chao J
Am J Physiol Heart Circ Physiol; 2010 Nov; 299(5):H1419-27. PubMed ID: 20729399
[TBL] [Abstract][Full Text] [Related]
11. Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.
Yiu WH; Wong DW; Wu HJ; Li RX; Yam I; Chan LY; Leung JC; Lan HY; Lai KN; Tang SC
Kidney Int; 2016 Feb; 89(2):386-98. PubMed ID: 26536000
[TBL] [Abstract][Full Text] [Related]
12. Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress.
Chao J; Li P; Chao L
Biol Chem; 2017 Nov; 398(12):1309-1317. PubMed ID: 28742513
[TBL] [Abstract][Full Text] [Related]
13. Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway.
Chao J; Guo Y; Li P; Chao L
Oxid Med Cell Longev; 2017; 2017():5262958. PubMed ID: 29387292
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.
Kumarswamy R; Volkmann I; Jazbutyte V; Dangwal S; Park DH; Thum T
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):361-9. PubMed ID: 22095988
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-31 is a positive modulator of endothelial-mesenchymal transition and associated secretory phenotype induced by TGF-β.
Katsura A; Suzuki HI; Ueno T; Mihira H; Yamazaki T; Yasuda T; Watabe T; Mano H; Yamada Y; Miyazono K
Genes Cells; 2016 Jan; 21(1):99-116. PubMed ID: 26663584
[TBL] [Abstract][Full Text] [Related]
16. Kallistatin suppresses cancer development by multi-factorial actions.
Chao J; Li P; Chao L
Crit Rev Oncol Hematol; 2017 May; 113():71-78. PubMed ID: 28427524
[TBL] [Abstract][Full Text] [Related]
17. Novel role of kallistatin in vascular repair by promoting mobility, viability, and function of endothelial progenitor cells.
Gao L; Li P; Zhang J; Hagiwara M; Shen B; Bledsoe G; Chang E; Chao L; Chao J
J Am Heart Assoc; 2014 Sep; 3(5):e001194. PubMed ID: 25237049
[TBL] [Abstract][Full Text] [Related]
18. Regulation of TGF-β-mediated endothelial-mesenchymal transition by microRNA-27.
Suzuki HI; Katsura A; Mihira H; Horie M; Saito A; Miyazono K
J Biochem; 2017 May; 161(5):417-420. PubMed ID: 28338957
[TBL] [Abstract][Full Text] [Related]
19. MiR-200a modulates TGF-β1-induced endothelial-to-mesenchymal shift via suppression of GRB2 in HAECs.
Zhang H; Hu J; Liu L
Biomed Pharmacother; 2017 Nov; 95():215-222. PubMed ID: 28846982
[TBL] [Abstract][Full Text] [Related]
20. Kallistatin inhibits vascular inflammation by antagonizing tumor necrosis factor-alpha-induced nuclear factor kappaB activation.
Yin H; Gao L; Shen B; Chao L; Chao J
Hypertension; 2010 Aug; 56(2):260-7. PubMed ID: 20566960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
